|
Market Closed -
Australian S.E.
05:10:11 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 1.880 AUD | -2.84% |
|
+5.62% | +13.60% |
| 10-29 | PYC Therapeutics Held AU$655 Million Cash, Treasury Investments at September Quarter-End | MT |
| 09-21 | PYC Therapeutics Limited(ASX:PYC) added to S&P/ASX Small Ordinaries Index | CI |
Company Valuation: PYC Therapeutics Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 206.8 | 191.3 | 559.9 | 755.3 | 1,657 | 1,850 | - | - |
| Change | - | -7.47% | 192.66% | 34.9% | 119.41% | 11.65% | - | - |
| Enterprise Value (EV) 1 | 206.8 | 175.8 | 493.1 | 602.3 | 1,604 | 1,322 | 1,395 | 1,342 |
| Change | - | -15% | 180.54% | 22.15% | 166.27% | -17.54% | 5.47% | -3.8% |
| P/E | -14.8x | -7.89x | -12.5x | -12.9x | -28.5x | -23x | -22.4x | -27.2x |
| PBR | - | - | 5.85x | 3.82x | 1.78x | 3.12x | 3.23x | 3.53x |
| PEG | - | -0.1x | -0.4x | -2.75x | 0.7x | -0.6x | -8.5x | 1.5x |
| Capitalization / Revenue | - | 12x | 24.5x | 28.9x | 41.8x | - | - | - |
| EV / Revenue | - | 11x | 21.6x | 23x | 40.4x | - | - | - |
| EV / EBITDA | - | -7.83x | -13.3x | -12x | -37.7x | -12x | -8.15x | -9.17x |
| EV / EBIT | - | -7.53x | -13x | -11.8x | -36.7x | -11.1x | -7.92x | -9.73x |
| EV / FCF | - | -7.05x | -12.7x | -11.5x | -35.6x | -19x | -34.3x | -59.3x |
| FCF Yield | - | -14.2% | -7.89% | -8.72% | -2.81% | -5.26% | -2.92% | -1.69% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.044 | -0.071 | -0.096 | -0.1005 | -0.0591 | -0.0816 | -0.0838 | -0.069 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | 15.91 | 22.86 | 26.17 | 39.68 | - | - | - |
| EBITDA 1 | - | -22.45 | -36.99 | -50.35 | -42.52 | -110.4 | -171.2 | -146.3 |
| EBIT 1 | - | -23.33 | -38.06 | -50.95 | -43.73 | -118.6 | -176.1 | -138 |
| Net income 1 | -13.86 | -22.79 | -37.73 | -50.3 | -43.07 | -84.75 | -87.07 | -87.11 |
| Net Debt 1 | - | -15.57 | -66.87 | -153.1 | -53.56 | -527.9 | -455.6 | -508.5 |
| Reference price 2 | 0.650 | 0.560 | 1.200 | 1.295 | 1.685 | 1.880 | 1.880 | 1.880 |
| Nbr of stocks (in thousands) | 318,093 | 341,650 | 466,608 | 583,260 | 983,510 | 984,210 | - | - |
| Announcement Date | 30/08/22 | 31/08/23 | 29/08/24 | 28/08/25 | 28/08/26 | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -23.04x | - | -11.98x | - | 1.3B | |
| 16.87x | 6.34x | 12.15x | 1.77% | 63.77B | |
| 30.14x | 8.25x | 27.02x | 0.04% | 56.37B | |
| 37.48x | 6.65x | 19.85x | 0.86% | 54.62B | |
| 34.93x | 3.32x | 14.34x | -.--% | 44.06B | |
| 48.85x | 5.63x | 30.81x | -.--% | 42.11B | |
| -19.86x | 192.36x | -21.16x | -.--% | 41B | |
| 47.33x | 8.41x | 28.18x | -.--% | 34.92B | |
| 32x | 8.13x | 21.15x | 0.41% | 32.82B | |
| -64.56x | 13.05x | -73.23x | -.--% | 24.7B | |
| Average | 14.01x | 28.02x | 4.71x | 0.34% | 39.56B | |
| Weighted average by Cap. | 21.94x | 26.34x | 10.86x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PYC Stock
- Valuation PYC Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
